Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 1:23 AM
NCT ID:
NCT00003793
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of sarcoma including:
* Rhabdomyosarcoma
* Ewing's sarcoma
* Primitive neuroectodermal tumor
* Fibrosarcoma
* Malignant peripheral nerve sheath tumor
* Synovial cell sarcoma
* Osteosarcoma
* Other soft tissue sarcoma
* Must be currently receiving intensive or high-dose chemotherapy for sarcoma
PATIENT CHARACTERISTICS:
Age:
* Children
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* See Disease Characteristics
Endocrine therapy
* Not specified
Radiotherapy
* Not specified
Surgery
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
17 Years
Study:
NCT00003793
Study Brief:
Protocol Section:
NCT00003793